Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Consolidation After CCRT in Locally Advanced Cervical Cancer
NCT04310774Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tegafur in Cervical Cancer (CC), sponsored by Peking Union Medical College Hospital. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
tegafur
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04310774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04310774.